These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 19691583)
21. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases. Steppich BA; Seitz I; Busch G; Stein A; Ott I Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232 [TBL] [Abstract][Full Text] [Related]
22. Protein S enhances the tissue factor pathway inhibitor inhibition of factor Xa but not its inhibition of factor VIIa-tissue factor. Ndonwi M; Broze G J Thromb Haemost; 2008 Jun; 6(6):1044-6. PubMed ID: 18419747 [No Abstract] [Full Text] [Related]
23. The extrinsic pathway inhibitor: a regulator of tissue factor-dependent blood coagulation. Rapaport SI Thromb Haemost; 1991 Jul; 66(1):6-15. PubMed ID: 1926052 [No Abstract] [Full Text] [Related]
24. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels. Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632 [TBL] [Abstract][Full Text] [Related]
25. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells. Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145 [TBL] [Abstract][Full Text] [Related]
26. [Levels of plasma TF and TFPI activities in patients with acute leukemia]. Zhu Y; Xie ZX; He XF; Han JZ; Li JC; He SL Hunan Yi Ke Da Xue Xue Bao; 2000 Aug; 25(4):401-2, 405. PubMed ID: 12206017 [TBL] [Abstract][Full Text] [Related]
27. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques. Migdalski A; Kotschy M; Jawien A Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981 [TBL] [Abstract][Full Text] [Related]
29. Heparanase coagulation and cancer progression. Nadir Y; Brenner B Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275 [TBL] [Abstract][Full Text] [Related]
36. Long-term incubation with IL-4 and IL-10 oppositely modifies procoagulant activity of monocytes and modulates the surface expression of tissue factor and tissue factor pathway inhibitor. Paysant J; Soria C; Cornillet-Lefèbvre P; Nguyen P; Lenormand B; Mishal Z; Vannier JP; Vasse M Br J Haematol; 2005 Nov; 131(3):356-65. PubMed ID: 16225656 [TBL] [Abstract][Full Text] [Related]
37. Impact of serum amyloid A on tissue factor and tissue factor pathway inhibitor expression and activity in endothelial cells. Zhao Y; Zhou S; Heng CK Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1645-50. PubMed ID: 17463335 [TBL] [Abstract][Full Text] [Related]
38. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Amengual O; Atsumi T; Khamashta MA; Hughes GR Thromb Haemost; 1998 Feb; 79(2):276-81. PubMed ID: 9493575 [TBL] [Abstract][Full Text] [Related]
39. Heparanase procoagulant effects and inhibition by heparins. Nadir Y; Brenner B Thromb Res; 2010 Apr; 125 Suppl 2():S72-6. PubMed ID: 20434010 [TBL] [Abstract][Full Text] [Related]
40. A Pilot Study of Tissue Factor-Tissue Factor Pathway Inhibitor Axis and Other Selected Coagulation Parameters in Broiler Chickens Administered in Ovo with Selected Prebiotics*. Buzala M; Ponczek MB; Slomka A; Roslewska A; Janicki B; Zekanowska E; Bednarczyk M Folia Biol (Krakow); 2016; 64(4):213-224. PubMed ID: 29809360 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]